GLASODEX

GLASODEX BICALUTAMIDE TABLETS USP 50 MG
• For the treatment of Metastic prostate Cancer ( mPC) in men in combination with a gonadotropin – releasing hormone ( GnRH ) analogue or surgical castration at moderate doses.
• For the treatment of Locally advanced prostrate cancer ( LAPC ) in men as a monotherapy in high doses.

Category:

COMPOSITION
Each film coated tablet contains:
Bicalutamide USP                                             50mg
Excipients                                                   q.s
Colour:                                                      Titanium Dioxide
 
CLINICAL PHARMACOLOGY
Mechanism of action
Bicalutamide is a non-steroidal androgen receptor inhibitor. It competitively inhibits the action of androgens by binding to cytosol and logen receptors in the target tissue. Prostatic carcinoma is known to be androgen sensitive and responds to treatment that counteracts the effects of androgen and / or removes the source of androgen.

There are no reviews yet.

Be the first to review “GLASODEX”